Yousef Malik, Kumar Abhishek, Bakir-Gungor Burcu
Department of Information Systems, Zefat Academic College, Zefat 13206, Israel.
Galilee Digital Health Research Center (GDH), Zefat Academic College, Zefat 13206, Israel.
Entropy (Basel). 2020 Dec 22;23(1):2. doi: 10.3390/e23010002.
In the last two decades, there have been massive advancements in high throughput technologies, which resulted in the exponential growth of public repositories of gene expression datasets for various phenotypes. It is possible to unravel biomarkers by comparing the gene expression levels under different conditions, such as disease vs. control, treated vs. not treated, drug A vs. drug B, etc. This problem refers to a well-studied problem in the machine learning domain, i.e., the feature selection problem. In biological data analysis, most of the computational feature selection methodologies were taken from other fields, without considering the nature of the biological data. Thus, integrative approaches that utilize the biological knowledge while performing feature selection are necessary for this kind of data. The main idea behind the integrative gene selection process is to generate a ranked list of genes considering both the statistical metrics that are applied to the gene expression data, and the biological background information which is provided as external datasets. One of the main goals of this review is to explore the existing methods that integrate different types of information in order to improve the identification of the biomolecular signatures of diseases and the discovery of new potential targets for treatment. These integrative approaches are expected to aid the prediction, diagnosis, and treatment of diseases, as well as to enlighten us on disease state dynamics, mechanisms of their onset and progression. The integration of various types of biological information will necessitate the development of novel techniques for integration and data analysis. Another aim of this review is to boost the bioinformatics community to develop new approaches for searching and determining significant groups/clusters of features based on one or more biological grouping functions.
在过去二十年中,高通量技术取得了巨大进展,这导致了各种表型的基因表达数据集公共存储库呈指数级增长。通过比较不同条件下的基因表达水平,如疾病与对照、治疗与未治疗、药物A与药物B等,有可能揭示生物标志物。这个问题涉及机器学习领域中一个研究充分的问题,即特征选择问题。在生物数据分析中,大多数计算特征选择方法都借鉴了其他领域,而没有考虑生物数据的本质。因此,对于这类数据,在进行特征选择时利用生物知识的综合方法是必要的。综合基因选择过程背后的主要思想是,在考虑应用于基因表达数据的统计指标以及作为外部数据集提供的生物背景信息的同时,生成一个基因排名列表。本综述的主要目标之一是探索现有的整合不同类型信息的方法,以改进疾病生物分子特征的识别和新潜在治疗靶点的发现。这些综合方法有望有助于疾病的预测、诊断和治疗,以及让我们了解疾病状态动态、发病机制和进展情况。各种类型生物信息的整合将需要开发新的整合和数据分析技术。本综述的另一个目的是推动生物信息学界开发新方法,以基于一种或多种生物分组功能搜索和确定重要的特征组/簇。